The article describes the results of the development of the composition and technology of capsules based on the substances metronidazole, drotaverine and furadonin for the treatment of urological diseases. The choice of excipients included in the capsules is based on the compatibility of the components with the physicochemical and technological properties of the substance, the form of nutrition and the areas of application of the drug.